Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Agile Therapeutics Inc AGRX

Alternate Symbol(s):  AGXRW

Healthcare
Agile Therapeutics, Inc. is a women's healthcare company, which is engaged in fulfilling the unmet health needs of women. The Company’s sole approved product, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch. Twirla is a method of contraception for use in women of reproductive potential for whom a combined hormonal contraceptive is appropriate. Twirla is a... see more

Recent & Breaking News (OTCQB:AGRX)

Corium Pharma Solutions Names Ernie De Paolantonio as Chief Financial Officer

PR Newswire February 15, 2023

Corium Pharma Solutions Names Two Industry Veterans to its Executive Team

PR Newswire February 9, 2023

Agile Therapeutics Provides Clinical Update on Twirla and Status of Pipeline Evaluation

GlobeNewswire February 1, 2023

Agile Therapeutics Announces Distribution of Series C Preferred Stock to its Holders of Common Stock

GlobeNewswire January 26, 2023

Agile Therapeutics: This BioPharma Firm Is Nimbly Solving Unmet Needs For Women

TheNewsWire January 20, 2023

Agile Therapeutics Provides Updates on 2022 Twirla Performance and 2023 Commercial Plan

GlobeNewswire January 9, 2023

This Biotech Company is Pursuing Positive Cash Flow In 2023

TheNewsWire December 21, 2022

Agile Therapeutics To Present At The Upcoming RHK Capital Disruptive Growth Conference

GlobeNewswire December 1, 2022

Women’s Healthcare Company Agile Therapeutics Says It Believes It Has An Effective Business Plan In Place For Growth And Generating Positive Cash Flow

TheNewsWire November 15, 2022

Agile Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update

GlobeNewswire November 7, 2022

Agile Therapeutics to Report Third Quarter 2022 Financial Results and Provide Business Update on Monday, November 7, 2022

GlobeNewswire October 26, 2022

Can This Company’s Birth Control Patch Disrupt The Contraceptive Market?

TheNewsWire October 26, 2022

NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022

TheNewsWire October 21, 2022

Agile Therapeutics Announces Reorganization of Leadership Team

GlobeNewswire October 7, 2022

Agile Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference

GlobeNewswire September 6, 2022

Agile Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update

GlobeNewswire August 11, 2022

Agile Therapeutics to Report Second Quarter 2022 Financial Results and Provide Business Update on Thursday, August 11, 2022

GlobeNewswire July 28, 2022

Agile Therapeutics Updates Second Quarter 2022 Guidance

GlobeNewswire July 12, 2022

Agile Therapeutics to Participate in Maxim Group's Upcoming Women's Health Panel

GlobeNewswire July 8, 2022

Agile Therapeutics Announces Closing of $24 Million Upsized Public Offering

GlobeNewswire July 6, 2022